# Angiography-derived FFR GPS in Predicting Post-PCI Physiological and Clinical Outcomes

> **NCT05496023** · — · UNKNOWN · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 329 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Percutaneous coronary intervention

## Key facts

- **NCT ID:** NCT05496023
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01-01
- **Primary completion:** 2022-08-30
- **Final completion:** 2022-10-01
- **Target enrollment:** 329 (ESTIMATED)
- **Last updated:** 2022-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05496023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05496023, "Angiography-derived FFR GPS in Predicting Post-PCI Physiological and Clinical Outcomes". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05496023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*